John Zaia

Pages Tagged with "John Zaia"

Celebrating ‘everyday heroes’ during hospital week
National Hospital Week is an opportunity to highlight hospitals, health systems and health care workers and the innovative ways they are supporting and connected to patients and the community. As...
The road to comprehensive cancer care
“People thought City of Hope was a ship!”   It’s hard to believe, but there was a time when the sprawling, globally recognized City of Hope we all recognize today...
City of Hope physicians/scientists lead multiple, innovative COVID-19 research projects
CONTACT Letisia Marquez 626-476-7593lemarquez@coh.org   Chimeric antigen receptor (CAR)-NK cell therapy to treat the virus is one of more than two dozen COVID-19 research projects underway   DUARTE, Calif...
City of Hope Enters Commercial License Agreement to Use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform
CONTACT Letisia Marquez 626-476-7593lemarquez@coh.org   DUARTE, Calif. — ProBioGen AG has announced a commercial product license agreement with City of Hope®, a world-renowned independent research and treatment center for...
City of Hope COVID-19 vaccine shows effectiveness in Phase 1 trial
A COVID-19 investigational vaccine developed by City of Hope scientists and now licensed to GeoVax Labs Inc. produced a robust neutralizing antibody and T cell (an immune cell) response against...
City of Hope initiates phase 1 clinical trial to test its first SARS-CoV-2 investigational vaccine
CONTACT Letisia Marquez 626-476-7593lemarquez@coh.org   •    The vaccine strategy used to generate this candidate has a record of safety and efficacy, rapid immune response and lasting protection   •  ...
Cancer care predictions 2020: The best is yet to come
Cancer care is changing rapidly, and the pace of change is accelerating. In 2019, major advances in precision medicine, gene-based therapy, immunotherapy and many other areas brought new hope to...
City of Hope to begin CIRM-funded coronavirus study
John Zaia, M.D. The California Institute for Regenerative Medicine (CIRM) awarded $750,000 to City of Hope’s John Zaia, M.D., for a clinical study on the use of blood plasma as a...
City of Hope scientists present research at LABEST
City of Hope’s position as a leader in research and bioscience was once again evident at the recent Los Angeles Bioscience Ecosystem Summit (LABEST), the premier showcase for bioscience innovation...
City of Hope opens clinical trial for coronavirus vaccine
City of Hope has initiated a phase 1 clinical trial that will test one of its investigational SARS-CoV-2 vaccines in healthy volunteers from the ages of 18 to 54 who have not...